Spots Global Cancer Trial Database for Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
Official Title: Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
Study ID: NCT03104478
Conditions
Interventions
Study Description
Brief Summary: The trial will enroll 194 previously untreated DLBCL patients over 20 months, with the objective to send to the local investigator an extensive molecular tumor characterization by D38 in at least 80% of enrolled patients. The feasibility and efficiency will be demonstrated by deploying and operating a nation-wide network of dedicated multidisciplinary platforms.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU Caen, Caen, , France
Hopital Henri Mondor, Creteil, , France
CHU Le Bocage, Dijon, , France
CH Départemental, La Roche sur Yon, , France
CHU Claude Hurriez, Lille, , France
CHU Montpellier, MONTPELLIER Cedex 5, , France
CHU de Nantes, Nantes, , France
Centre Francois Magendie, Pessac, , France
CHU Lyon Sud, Pierre Bénite cedex, , France
CHU de Poitiers - Hôpital de la Miletrie, Poitiers, , France
Ch Annecy Genevois, Pringy, , France
Centre Henri Becquerel, Rouen, , France
IUCT Oncopôle - CHU de Toulouse, Toulouse, , France
CHU Nancy Brabois, Vandoeuvre Les Nancy, , France
Institut Gustave Roussy, Villejuif, , France
Contact Details
Name: Fabrice Jardin, Pr
Affiliation: Lymphoma Study Association
Role: PRINCIPAL_INVESTIGATOR
Name: Christiane Copie, Pr
Affiliation: Lymphoma Study Association
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
